CSIMarket


Pharming Group N v   (PHAR)
Other Ticker:  
 

Pharming Group N v

PHAR's Fundamental analysis








Looking into Pharming Group N V growth rates, revenue grew by 3.39 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 2367

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -2.27 %

Pharming Group N V 's net profit deacreased by -14.52 % in IV. Quarter 2022 year on year, to $14 millions.

More on PHAR's Growth


Pharming Group N V
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 41.25 in trailing twelve-month period.
Company
578.95
PE TTM   
Industry
268.03
PE TTM    
Company's Price to Sales ratio is at 38.5.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.7.


More on PHAR's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,142,344
 Net Income/Employee (TTM) $ 75,967
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.28

Pharming Group N V
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 41.25 in trailing twelve-month period.
Company
578.95
PE TTM   
Industry
268.03
PE TTM    
Company's Price to Sales ratio is at 38.5.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.7.

Pharming Group N V Price to Book Ratio is at 38.69 lower than Indusry Avg. of 1282.51. and higher than S&P 500 Avg. of 0.01

More on PHAR's Valuation

  Market Capitalization (Millions $) 7,917
  Shares Outstanding (Millions) 720
  Employees 180
  Revenues (TTM) (Millions $) 206
  Net Income (TTM) (Millions $) 14
  Cash Flow (TTM) (Millions $) 192
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 1,142,344
  Net Income/Employee(TTM) $ 75,967
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 0.28

  Market Capitalization (Millions $) 7,917
  Shares Outstanding (Millions) 720
  Employees 180
  Revenues (TTM) (Millions $) 206
  Net Income (TTM) (Millions $) 14
  Cash Flow (TTM) (Millions $) 192
  Capital Exp. (TTM) (Millions $) -1


    PHAR's Profitability Comparisons
Pharming Group N V